JFS Wealth Advisors’s Insmed INSM Stock Holding History

JFS Wealth Advisors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.05K	Buy	38 +1	+3%	+$121	﹤0.01%	1364
2026 Q1	$6.05K	Sell	37 -2	-5%	-$307	﹤0.01%	1126
2025 Q4	$6.79K	Buy	39 +8	+26%	+$1.46K	﹤0.01%	1123
2025 Q3	$4.46K	Buy	31 +1	+3%	+$123	﹤0.01%	1159
2025 Q2	$3.02K	Sell	30 -28	-48%	-$2.14K	﹤0.01%	1267
2025 Q1	$4.42K	Sell	58 -10	-15%	-$765	﹤0.01%	1163
2024 Q4	$4.7K	Hold	68	–	–	﹤0.01%	1152
2024 Q3	$4.96K	Buy	68 +20	+42%	+$1.48K	﹤0.01%	1123
2024 Q2	$3.22K	Buy	48 +21	+78%	+$814	﹤0.01%	1243
2024 Q1	$733	Hold	27	–	–	﹤0.01%	1724
2023 Q4	$837	Buy	27 +3	+13%	+$78	﹤0.01%	1687
2023 Q3	$606	Buy	+24	New	+$549	﹤0.01%	1711
2023 Q2	–	Sell	-9	Closed	-$154	–	1999
2023 Q1	$154	Buy	+9	New	+$175	﹤0.01%	1854

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

JFS Wealth Advisors's INSM Position: Q2 2026 in Review

JFS Wealth Advisors increased its Insmed (INSM) stake by 2.7% in Q2 2026, buying an estimated $121 and bringing the position to 38 shares worth $4.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1364.

JFS Wealth Advisors first reported a position in INSM in Q1 2023 and has held it in 13 quarters since. The position peaked at $6.79K in Q4 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

JFS Wealth Advisors held 38 shares of Insmed worth $4.05K as of Q2 2026.
JFS Wealth Advisors bought 1 Insmed share in Q2 2026, an estimated $121.
Insmed made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #1364 holding.
JFS Wealth Advisors first reported a position in Insmed in Q1 2023 and has held it in 13 quarters since.
JFS Wealth Advisors's Insmed position peaked at $6.79K in Q4 2025.
663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.